MYRIAD GENETICS INC
Public company- Headquarters
- SALT LAKE CITY, Utah
- Ticker
- MYGN
- CIK
- 0000899923
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Commercial OfficerBrian Donnelly | Oct 9, 2026 | Departed |
| Executive Vice President, CommercialVishal Sikri | Sep 16, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- QuidelOrtho Corp
Head of Point of Care Diagnostics appointed: Jonathan Siegrist, PhD
- ACHIEVE LIFE SCIENCES, INC.
CFO appointed: Benjamin Halladay
- Q/C TECHNOLOGIES, INC.
CTO appointed: Yossef Ehrlichman
- NEOGEN CORP
Director departs: Thierry Bernard
- Executive departure
Chief Commercial Officer departs: Brian Donnelly
Brian Donnelly, Chief Commercial Officer of MYRIAD GENETICS INC, departs the role, effective September 16, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 9, 2026Role: Chief Commercial Officer
- Executive departure
Chief Commercial Officer departs: Brian Donnelly
Brian Donnelly, Chief Commercial Officer of MYRIAD GENETICS INC, departs the role, effective September 16, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 16, 2026Role: Chief Commercial Officer
- Executive appointment
Executive Vice President, Commercial appointed: Vishal Sikri
Vishal Sikri was named Executive Vice President, Commercial of MYRIAD GENETICS INC, effective September 16, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 16, 2026Role: Executive Vice President, Commercial
Last verified Nov 8, 2026